Revenue grew 4.3% quarter-on-quarter to BRL 372 million, with adjusted net income up 8.8% and strong cash generation. Churn hit a five-year Q3 low, and a record 340 new products were launched, while judicial claims and competitive SME pricing remain key risks.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.